Supply Chain Intelligence

Odyssey Therapeutics, Inc. Supply Chain

ODTX supply chain intelligence for Odyssey Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ODTX ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
2Customers
1Debt Items
17Related Chains

Odyssey Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
CANTOR-FITZGERALD-CO CANTOR-FITZGERALD-CO 90% J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., Wedbush & Co., LLC and Oppenheimer and Co. Inc. acted as placement agents for the Private Placement
J-P-MORGAN-SECURITIES-LLC J-P-MORGAN-SECURITIES-LLC 90% J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., Wedbush & Co., LLC and Oppenheimer and Co. Inc. acted as placement agents for the Private Placement
OPPENHEIMER-AND-CO-INC OPPENHEIMER-AND-CO-INC 90% J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., Wedbush & Co., LLC and Oppenheimer and Co. Inc. acted as placement agents for the Private Placement
TD-SECURITIES-USA-LLC TD-SECURITIES-USA-LLC 90% J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., Wedbush & Co., LLC and Oppenheimer and Co. Inc. acted as placement agents for the Private Placement
WEDBUSH-CO-LLC WEDBUSH-CO-LLC 90% J.P. Morgan Securities LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., Wedbush & Co., LLC and Oppenheimer and Co. Inc. acted as placement agents for the Private Placement
NKTR Nektar Therapeutics 72% Reciprocal relationship from NKTR graph: n. Please refer to Item 1A. Risk Factors, including without limitation, “We may not be able to obtain intellectual property licenses related to the developmen…

Odyssey Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
TPG-LSI-RISE-ORAZIO-II-L-P TPG-LSI-RISE-ORAZIO-II-L-P 92% On May 7, 2026, Odyssey Therapeutics, Inc. (the “ Company ”) entered into a Share Purchase Agreement (the “ Purchase Agreement ”) with TPG LSI Rise Orazio II, L.P. (" Purchaser "), an affiliate of an…
NKTR Nektar Therapeutics 72% Reciprocal relationship from NKTR graph: to target the TNFR2 pathway and include Dualyx, TRexBio, Inc., Odyssey Therapeutics, Inc., and Pfizer, Inc. Research and Development Our total research and de…

Odyssey Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ODTX-DEBT Debt stack $34.4M 90% Market cache reports total debt of $34.4M.

Odyssey Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Odyssey Therapeutics, Inc..

Odyssey Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Odyssey Therapeutics, Inc..

Odyssey Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SGMO Sangamo Therapeutics, Inc. 100.00 2
ASND Ascendis Pharma A/S 100.00 2
SNYNF Sanofi 100.00 2
TAK Takeda Pharmaceutical Company Limited 100.00 2
LLY Eli Lilly and Company 100.00 2
HCWB HCW Biologics Inc. 100.00 2
IMA ImageneBio, Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
PLRX Pliant Therapeutics, Inc. 50.00 2
BHC Bausch Health Companies Inc. 50.00 2
FLG Flagstar Bank, National Association 50.00 2
IOBTQ IO Biotech, Inc. 50.00 2
PSTV Plus Therapeutics, Inc. 50.00 2
NKTR Nektar Therapeutics 36.29 1 ['customer', 'supplier']
KRC Kilroy Realty Corporation 14.78 2
NVO Novo Nordisk A/S 14.78 2
CTMX CytomX Therapeutics, Inc. 14.78 2
View ODTX supply chain intel →

Explore the full interactive supply chain map for Odyssey Therapeutics, Inc..

Open ODTX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map